课题基金 / 基金详情

I-Corps: Data2Discovery: DataHub Platform for Drug Safety Analysis

I-Corps: Data2Discovery: DataHub Platform for Drug Safety Analysis
I-Corps:Data2Discovery:用于药物安全分析的 DataHub 平台
批准号:
1505374
负责人:
Ying Ding
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-01-01 至 2015-06-30

项目摘要

项目成果

Ying Ding的其他基金

相关文献

中文摘要
翻译
药物安全的一个关键障碍是无法以综合的方式利用公共数据资源来充分了解药物和化合物对生物系统的作用。有必要整合有关化合物、药物、靶标、基因、疾病、临床试验和已知药物副作用的异构数据集,并开发有效的网络数据分析技术来识别或预测重要的生物学关系。这些综合和相关的信息可用于支持药物开发、药物副作用评价和相关科学研究和评估的实践。这项工作还可以应用于分析患者的支付模式,预测他们对未来账单的支付能力,并通过分析患者的监测数据来推荐更好的生活方式。这可以节省人工搜索和分析数据的成本,避免人工产生的错误,并使医疗保健预算专注于为社会带来更好的医疗保健的严格问题。提出的技术(Data2Discovery DataHub Platform)使用语义集成和搜索技术来集成与药物安全相关的孤立数据源,并使搜索能够发现和解释使用其他方法很难或不可能找到的关联。该团队将寻求将以下工具或方法商业化:1)DataHub集成:将与药物安全相关的数据源集成到图形数据库中,并连接不同数据集的相关实体;2) DataHub Browser:允许用户浏览不同数据集的数据/实体;3) DataHub Predictor:基于预定义路径模式和生物相似性预测语义关联。这些工具可用于促进领域专家产生假设,并帮助最终用户了解他们正在服用的药物的副作用。这些技术有可能彻底改变从重要数据集庞大、复杂和异构的领域(如医疗保健、生命科学和业务分析)的数据中获取知识的方式。
英文摘要
A critical barrier in drug safety is the inability to utilize public data resources in an integrated fashion to fully understand the actions of drugs and chemical compounds on biological systems. There is a need to integrate the heterogeneous datasets pertaining to compounds, drugs, targets, genes, diseases, clinical trials, and known drug side effect, and to develop effective network data analytical techniques to identify or predict important biological relationships. The integrated and associated information can be used to support practices in drug development, evaluation of drug side effects, and related scientific research and assessment. The proposed work can also be applied to analyze patient payment patterns and predict their paying capability for coming bills, and recommend better life-style by analyzing monitoring data from patients. This can save cost of manual labor for searching and analyzing data, and avoid errors generated by manual labor, and allows healthcare budget focus on stringent issues of bringing better healthcare for the society.The proposed technology (Data2Discovery DataHub Platform) uses semantic integration and searching technologies to integrate siloed data sources related to drug safety and enables search to find and interpret associations which are hard or impossible to find using other methods. The team will seek to commercialize the following tools or approaches: 1) DataHub Integration: integrating data sources related to drug safety into a graph database and connecting related entities across different datasets; 2) DataHub Browser: allowing users to browse data/entities across different datasets; and 3) DataHub Predictor: predicting semantic association based on pre-defined path patterns and biological similarities. These tools can be used to facilitate domain experts to generate hypotheses, and end users to understand side effects of drugs that they are taking. These technologies have the potential to revolutionize how knowledge is derived from data in domains where the important datasets are large, complex and heterogeneous, such as healthcare, life science and business analytics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conference: Travel: III: Student Travel Support for 2024 ACM The Web Conference (TheWebConf)
  • 批准号:
    2412369
  • 项目类别:
    Standard Grant
  • 资助金额:
    $2.0万
  • 财政年份:
    2024
  • 负责人:
    Ying Ding
  • 依托单位:
I-Corps: Contextualization of Explainable Artificial Intelligence (AI) for Better Health
  • 批准号:
    2331366
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2023
  • 负责人:
    Ying Ding
  • 依托单位:
Collaborative Research: NSF-CSIRO: RESILIENCE: Graph Representation Learning for Fair Teaming in Crisis Response
  • 批准号:
    2303038
  • 项目类别:
    Standard Grant
  • 资助金额:
    $29.99万
  • 财政年份:
    2023
  • 负责人:
    Ying Ding
  • 依托单位:
RAPID: Dashboard for COVID-19 Scientific Development
  • 批准号:
    2028717
  • 项目类别:
    Standard Grant
  • 资助金额:
    $19.86万
  • 财政年份:
    2020
  • 负责人:
    Ying Ding
  • 依托单位: